NovoCure Limited (NVCR)

NovoCure Limited (NVCR $12.81)
- $12.81 Cap: $1.43B
- View NVCR Profile
- View Questions on NVCR

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Bristol-Myers Squibb Company (BMY $46.07)
- $46.07 P/E (TTM): 17.11X Cap: $92.85B
- View BMY Profile
- View Questions on BMY
NovoCure Limited (NVCR $12.81)
- $12.81 Cap: $1.43B
- View NVCR Profile
- View Questions on NVCR

Q: What are your thoughts on BMY with the acquisitions and deals they've completed in 2024 and 2025?

What are your thoughts on Novocure as a hold over the next 3 years?

What are your thoughts on Summit Therapeutics as a small speculative position?

Read Answer Asked by Frederick on October 27, 2025

Twilio Inc. Class A (TWLO $134.88)
- $134.88 P/E (TTM): 1116.1X Cap: $17.31B
- View TWLO Profile
- View Questions on TWLO
NovoCure Limited (NVCR $12.81)
- $12.81 Cap: $1.43B
- View NVCR Profile
- View Questions on NVCR
Fastly Inc. Class A (FSLY $8.29)
- $8.29 Cap: $1.17B
- View FSLY Profile
- View Questions on FSLY
Lemonade Inc. (LMND $60.08)
- $60.08 Cap: $4.43B
- View LMND Profile
- View Questions on LMND
Unity Software Inc. (U $37.90)
- $37.90 Cap: $16.01B
- View U Profile
- View Questions on U

Q: I own the following in my TFSA - LMND, NVCR, U, FSLY, TWLO. All are down significantly and make up only a small percentage of the total TFSA. Because I can not take a tax loss, would you recommend leaving them tucked away for now? In other words, do any have good potential? Or would you recommend selling and investing elsewhere? Thanks.

Read Answer Asked by Kim on August 22, 2024

NovoCure Limited (NVCR $12.81)
- $12.81 Cap: $1.43B
- View NVCR Profile
- View Questions on NVCR
DermTech Inc (DMTK)
- Cap: $3M
- View DMTK Profile
- View Questions on DMTK

Q: Two companies so please go ahead and take two credits to allow for a detailed reply for each.

DMTK: Any life in this? I have always loved the idea of accurate, non-invasive skin cancer detection but this has not done well. Is there upside at current levels or is it likely to be bought out? It's hard to see how the tech is not more widely adopted by doctors.

NVCR: What happened to this one? Problem with their technology or just not producing numbers to keep Wall St. happy? Any upside given the extreme pullback?

Read Answer Asked by Tim on August 09, 2023